WebStatera Biopharma, Inc. (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. WebSep 7, 2024 · Cytocom acquired ImQuest Life Science, Inc. in an all-stock deal on June 23, 2024, and provided an update on its integration on September 1. Together, these entities will strengthen and expand...
Statera Biopharma Announces CEO Mike Handley to Speak
WebSep 28, 2024 · Cytocom issued the 125,000 shares of its common stock on March 4, 2024. Due to the fact that Cytocom did not have sufficient funds by January 25, 2024, it was unable to meet its payment obligations to Ira Gaines and the Gaines Trust due on that date. The $50,000 payment was made on June 9, 2024. WebStatera Biopharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis. first security bank mountain home ar 72653
Cytocom, Inc. completed the acquisition of Cleveland BioLabs, Inc.
WebAug 13, 2024 · Cytocom, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a … WebOct 6, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers ... WebJan 24, 2024 · Statera Biopharma (formerly Cytocom, Inc.) is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers ... camouflage moving service san antonio